Polymorphism and the analgesic activity of N-(3-pyridylmethyl)-4-hydroxy-2-oxo-1,2,5,6,7,8-hexahydroquinoline-3-carboxamide

Authors

  • I. V. Ukrainets National University of Pharmacy, Ukraine
  • O. V. Mospanova Kyiv National University of Technologies and Design, Ukraine
  • N. L. Bereznyakova National University of Pharmacy, Ukraine
  • O. O. Davydenko National Pirogov Memorial Medical University, Ukraine

DOI:

https://doi.org/10.24959/ophcj.15.832

Keywords:

4-hydroxy-2-oxo-1, 2-dihydroquinoline-3-carboxamides, polymorphism, X-ray structural analysis, analgesic activity

Abstract

The advanced study of the analgesic activity of N-(3-pyridylmethyl)-4-hydroxy-2-oxo-1,2,5,6,7,8-hexahydroquinoline-3-carboxamide selected by the results of the primary pharmacological screening as the leading structure has revealed a significant change in anesthetic properties in different samples of this compound. Since the substance under study was not soluble in water, and animals received it orally as a thin aqueous suspension, the most likely cause of the effect observed was thought to be the changes in the crystalline structure of N-(3-pyridylmethyl)-4-hydroxy-2-oxo-1,2,5,6,7,8-hexahydroquinoline-3-carboxamide occurring in it under the influence of external factors. This assumption has been fully confirmed by the thorough microscopic investigation of righ – and low-active samples, as well as more objective data, the methods of powder and single crystal X-ray diffraction analysis. Thus, in particular, it has been found that with all the variety of crystalline and amorphous forms included in the samples studied their qualitative composition appeared to be quite similar. At the same time the quantitative content of some of the phases varies greatly, and obviously, it was the factor determining the size of the analgesic effect.

Downloads

Download data is not yet available.

References

  1. Muresan-Pop M., Braga D., Pop M. M., Borodi G., Kacso I., Maini L. Journal of pharmaceutical sciences, 2014, Vol. 103, No.11, pp.3594-3601. DOI: 10.1002/jps.24151.
  2. Nyström M., Roine J., Murtomaa M., Mohan Sankaran R., Santos H. A., Salonen J. European journal of pharmaceutics and biopharmaceutics, 2014, DOI: 10.1016/j.ejpb.2014.11.027.
  3. Blandizzi C., Viscomi G. C., Scarpignato C. Drug design, development and therapy, 2015, Vol. 9, pp.1-11. DOI: 10.2147/DDDT.S72572.
  4. Gana I., Barrio M., Do B., Tamarit J. L., Céolin R., Rietveld I. B. International journal of pharmaceutics, 2013, Vol. 456, No.2, pp.480-488. DOI: 10.1016/j. ijpharm.2013.08.031.
  5. Patil S. S., Mahadik K. R., Paradkar A. R. European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences, 2015, Vol. 68, pp.43-50. DOI: 10.1016/j.ejps.2014.11.007.
  6. Du Y., Zhang H., Xue J., Tang W., Fang H., Zhang Q., Li Y., Hong Z. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2015, Vol. 137, pp.1158-1163. DOI: 10.1016/j.saa.2014.08.128.
  7. Marques M. P., Valero R., Parker S. F., Tomkinson J., Batista de Carvalho L. A. The journal of physical chemistry. B, 2013, Vol. 117, No.21, pp.6421-6429. DOI: 10.1021/jp403486z.
  8. Sorrenti M., Catenacci L., Cruickshank D. L., Caira M. R. Journal of pharmaceutical sciences, 2013, Vol. 102, No.10, pp.3596-3603. DOI: 10.1002/jps.23660.
  9. Russkiy khimicheskiy zhurnal – Russian chemical journal, 1997, Vol. XLI, No.5. The entire issue is devoted to the polymorphism of drugs and problems of a new generation of pharmacological agents.
  10. Bernstein J. Polymorphism in Molecular Crystals. Oxford, Clarendon Press, 2002, 428 p.
  11. Ukrainets I. V., Gorokhova O. V., Nidal Amin Jaradat, Petrushova L. A., Mospanova E. V., Savchenkova L. V., Kuz’min V. E., Lyahovsky A. V. 4-Hydroxyquinolin- 2-ones and their Close Structural Analogues as a New Source of Highly Effective Pain-killers. In book: Pain and Treatment, Racz G. B. and Noe C. E. (Ed.), Rijeka: InTech, 2014, pp.21-73.
  12. Ukrainets I. V., Kolesnik E. V., Sidorenko L. V., Gorokhova O. V., Turov A. V. Chemistry of Heterocyclic Compounds, 2006, Vol. 42, No.6, pp.765-775.
  13. Zefirov N. S., Palyulin V. A., Dashevskaya E. E. Journal of Physical Organic Chemistry, 1990, Vol. 3, No.3, pp.147-154. DOI: 10.1002/poc.610030304.
  14. Burgi H.-B., Dunitz J. D. Structure Correlation. Weinheim, VCH, 1994, Vol. 2, pp.741-784.
  15. Sheldrick G. M. Acta Crystallographica. Section A, 2008, Vol. 64, pp.112-122.
  16. Vogel H. G. Drug Discovery and Evaluation: Pharmacological Assays, Berlin, Springer, 2008, pp.1030-1032.
  17. Sigidin Ya. A., Shvarts G. Ya., Arzamastsev A. P., Liberman S. S. Drug Therapy of the Anti-inflammatory Process, Moscow, Meditsina, 1988, pp.60-63.

Downloads

Published

2015-06-10

How to Cite

(1)
Ukrainets, I. V.; Mospanova, O. V.; Bereznyakova, N. L.; Davydenko, O. O. Polymorphism and the Analgesic Activity of N-(3-Pyridylmethyl)-4-Hydroxy-2-Oxo-1,2,5,6,7,8-Hexahydroquinoline-3-Carboxamide. J. Org. Pharm. Chem. 2015, 13, 41-46.

Issue

Vol. 13 No. 2(50) (2015)

Section

Original Researches

License

Copyright (c) 2015 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:

1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.

3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).